Recruitment of women to clinical trials
The LancetPublished 1 September 2001Open access
The Lancet
Citations14
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Researchers are having difficulty in recruiting women to breast-cancer trials. Even women at high risk of developing breast cancer are not taking part in randomised controlled trials. As reported in a Research Letter this week (p 889), for the past 8 years in a region of the UK women who have a greater than 40% lifetime risk of breast cancer have been offered entry into two chemoprevention trials, or a study of risk-reducing mastectomy, or a study of breast screening by magnetic resonance imaging.
Keywords
Medicine